MedPath

Evaluation of Analgesia Nociception Index (ANI) During Propofol/Remifentanil and Sevoflurane/Remifentanil Anesthesia

Conditions
General Anaesthesia
Registration Number
NCT01522508
Lead Sponsor
University Hospital Schleswig-Holstein
Brief Summary

The aim of this prospective randomized study was to evaluate the ability of the new Analgesia Nociception Index ANI, derived by heart rate variability, to detect painful stimulation during either propofol or sevoflurane anesthesia and changing remifentanil concentrations.

Detailed Description

Monitoring Antinociception during general anesthesia is still a big challenge in the field and has not become clinical routine yet. Recently, for the Surgical Pleth Index SPI a benefit for the patient in terms of reduction of remifentanil use, less unwanted effects and shorter recovery from anesthesia was reported. However, there are new variables like the ANI that are developed to measure antinociception during anesthesia.

In the present study the investigators want to evaluate, whether ANI detects a painful tetanic stimulus during general anesthesia using propofol or sevoflurane and different concentrations of remifentanil.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • age between 18- 65 years,
  • ASA physical status I or II,
  • elective surgery in general anesthesia planned,
  • written informed consent
Exclusion Criteria
  • pregnancy,
  • history of cardiac arrhythmia,
  • presents of any neuromuscular or neurologic disease,
  • use of CNS-active medication or abuse of alcohol/illicit drugs -

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Kiel, Dept. of Anesthesiology and Intensive Care Med.

🇩🇪

Kiel, Germany

University Hospital Kiel, Dept. of Anesthesiology and Intensive Care Med.
🇩🇪Kiel, Germany
Berthold Bein, MD, PhD, DEAA
Principal Investigator
Matthias Gruenewald, MD
Principal Investigator
Christoph Ilies, MD
Sub Investigator
Jan Hoecker, MD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath